Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Disease 3 Prostatic Neoplasms 2 Colorectal Neoplasms 2 Sarcoma, Kaposi 1 Pain 1 Neoplasms 1 Lung Neoplasms 1 Gynecologic Cancer 1 Genetic Diseases, Inborn 1 Development of the Virtual Biopsy 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Chronic Pain 1 Castleman Disease 1 Cancer Pain 1 COVID-19 1 Breast Neoplasms 1 Brain Neoplasms 1 Anus Neoplasms 1 Adenoma 1

Interventions

Surveys and Questionnaires 6 Standard of Care 6 Blood Specimen Collection 6 BNT162 Vaccine 5 Hydroxychloroquine 4 Surgical Procedures, Operative 3 Specimen Handling 3 Practice Guidelines as Topic 3 COVID-19 Vaccines 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 Pandemic Preparedness 2 CVnCoV COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 ciclesonide 1 avdoralimab 1 XAV-19 1 Therapeutics 1 Telemedicine 1 Sperm Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × COVID-19 × Diagnostic Tests, Routine × Clear all

NCT04421625 2025-12-30

PAPESCO-19

Institut Cancerologie de l'Ouest

Phase NA Completed

1,102 enrolled 4 charts

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡